Dr. Droogmans Cardiologie SRL
Dr. Droogmans Cardiologie reported total assets of 50,659 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Dr. Droogmans Cardiologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -36 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Droogmans Cardiologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Dr. Droogmans Cardiologie's financial analysis
- Solvency40.4%sector median: 55.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Droogmans Cardiologie
Dr. Droogmans Cardiologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0707.999.436
- VAT number
- BE0707999436
- Peppol
- Registered · 0208:0707999436 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Oct 2018
- Registered office
- 1840 Londerzeel
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Other information service activities (NACE 63920)
Dr. Droogmans Cardiologie (SRL) has been based in Londerzeel since 2018, active in: other information service activities. For 2025, it reports a net profit of 29,874 € and equity of 20,441 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Droogmans Cardiologie
Companies in the same business, of comparable size and area, outside its group.
- LeVaGyn Medical specialists activities Antwerp · balance sheet 64,300 €
- Esteves Martins Yolande Melissa, Anesthesie Other information service activities Leuven · balance sheet 156,587 €
- PEDIATRIE Dr.DEVREKER-Dr.DECRAENE Medical specialists activities Schaerbeek · balance sheet 88,945 €
- Valesthesie Medical specialists activities Antwerp · balance sheet 132,336 €
- Umamed Medical specialists activities Destelbergen · balance sheet 17,042 €
- LV Endocrine Medical specialists activities Chaudfontaine · balance sheet 204,571 €
- Annelies Posen Medical specialists activities Tongeren-Borgloon · balance sheet 217,696 €
- Dokter Tine Loyson Medical specialists activities Sint-Niklaas · balance sheet 308,755 €
Frequently asked questions about Dr. Droogmans Cardiologie
What is the revenue of Dr. Droogmans Cardiologie?
Dr. Droogmans Cardiologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Droogmans Cardiologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0707999436 for Dr. Droogmans Cardiologie, if the company is VAT-registered. Its company number (CBE) is 0707.999.436.
Where is the registered office of Dr. Droogmans Cardiologie?
According to the CBE register, the registered office of Dr. Droogmans Cardiologie is in 1840 Londerzeel.
What is the equity of Dr. Droogmans Cardiologie?
At the close of the 2025 financial year, the equity of Dr. Droogmans Cardiologie amounts to 20,441 €, a solvency of 40.4% of total assets.
Who manages Dr. Droogmans Cardiologie?
The register lists 1 active mandates at Dr. Droogmans Cardiologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Droogmans Cardiologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →